SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-003492
Filing Date
2019-02-13
Accepted
2019-02-13 18:25:56
Documents
2
Period of Report
2019-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6490
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3494
  Complete submission text file 0000899243-19-003492.txt   11357
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Menzel Garry E (Reporting) CIK: 0001556064 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38811 | Film No.: 19599461

Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Issuer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)